Allergan Gets a Lift on Analyst Buzz

Now, AGN is pacing for its fifth straight win

Digital Content Manager
Jan 4, 2019 at 1:43 PM
facebook twitter linkedin

Allergan plc (NYSE:AGN) stock is attempting a comeback today, after a Mizuho Securities analyst said the stock was undervalued -- calling it "very salvageable and cheap." AGN stock took a recent hit after the recall of its textured breast implants in Europe, resulting in a five-year low of $125.84 on Dec. 26.

Today, though, AGN is pacing for its fifth straight win, with shares up 4.5% at $142.22, at last check. The Botox concern is now set to close back atop its 20-day moving average, a trendline it hasn't conquered since shortly after its October highs.

AGN since July 2018

Analysts are generally optimistic about Allergan stock, with 12 giving the security a "buy" or better rating, compared to five issuing "holds." What's more, the current consensus 12-month price target -- a lofty $207.11 per share -- represents expected upside of roughly 45% to current levels.

Options traders have a sunny outlook on AGN, too. Currently, the stock is sporting a Schaeffer's put/call open interest (SOIR) of 0.59 that sits in just the 4th percentile of its annual range. This suggests that short-term traders have rarely been more call-heavy in the past 12 months.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners